GPCR/G protein


All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
-
N2091 (+)- Corydaline -
N2538 Baohuoside I -
N2298 Xanthotoxol -
N2182 Harmine hydrochloride -
N2505 Scopolamine butylbromide -
N2189 Sinomenine Hydrochloride -
N2706 Synephrine -
BA2743 BarbadinSummary: Barbadin is a selective interaction inhibitor with values of 19.1 μM and 15.6 μM for β-arrestin1 and β-arrestin2, respectively. -
BA2745 OctreotideSummary: Octreotide (SMS201-995) is a growth inhibitor receptor agonist and synthetic octapeptide growth inhibitor analog. -
BA2748 DegarelixSummary: Degarelix is a competitive, reversible gonadotropin-releasing hormone receptor antagonist.

